KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Esperion Therapeutics (ESPR) Gross Profit (2019 - 2026)

Esperion Therapeutics filings provide 7 years of Gross Profit readings, the most recent being $46.0 million for Q3 2025.

  • On a quarterly basis, Gross Profit rose 33.99% to $46.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $176.8 million, a 26.65% decrease, with the full-year FY2024 number at $263.7 million, up 260.92% from a year prior.
  • Gross Profit hit $46.0 million in Q3 2025 for Esperion Therapeutics, down from $53.8 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $127.7 million in Q1 2024 to a low of $6.2 million in Q1 2021.
  • Median Gross Profit over the past 5 years was $20.6 million (2023), compared with a mean of $30.7 million.
  • Biggest five-year swings in Gross Profit: crashed 81.66% in 2021 and later surged 907.02% in 2024.
  • Esperion Therapeutics' Gross Profit stood at $10.3 million in 2021, then soared by 41.95% to $14.7 million in 2022, then surged by 41.89% to $20.8 million in 2023, then skyrocketed by 109.07% to $43.5 million in 2024, then grew by 5.84% to $46.0 million in 2025.
  • The last three reported values for Gross Profit were $46.0 million (Q3 2025), $53.8 million (Q2 2025), and $33.5 million (Q1 2025) per Business Quant data.